Function of P-glycoprotein expressed in placenta and mole.

We examined the expression of P-glycoprotein in human placentas and hydatidiform moles. Trophoblasts in all the examined placentas and moles expressed P-glycoprotein, and the size of the P-glycoprotein was smaller than that in multidrug-resistant human epidermoid carcinoma KB cells. The P-glycoprotein in the placenta and mole was photolabeled with [3H]azidopine, and [3H]vincristine was transported in an ATP-dependent manner into membrane vesicles prepared from trophoblasts that expressed P-glycoprotein. These findings indicate that P-glycoprotein expressed in trophoblasts has a drug binding site(s) and the ability to transport vincristine, suggesting that P-glycoprotein in the placenta protects the fetus from xenobiotics and confers drug resistance on moles.

[1]  I. Pastan,et al.  Genetic analysis of the multidrug transporter. , 1995, Annual review of genetics.

[2]  T. Ishikawa,et al.  ATP/Mg2+-dependent cardiac transport system for glutathione S-conjugates. A study using rat heart sarcolemma vesicles. , 1989, The Journal of biological chemistry.

[3]  T. Tsuruo,et al.  Expression of the MDR1 gene in human gastric and colorectal carcinomas. , 1990, Journal of the National Cancer Institute.

[4]  I. Pastan,et al.  The multidrug transporter, a double-edged sword. , 1988, The Journal of biological chemistry.

[5]  I. Pastan,et al.  Isolation and genetic characterization of human KB cell lines resistant to multiple drugs , 1985, Somatic cell and molecular genetics.

[6]  T. Tsuruo,et al.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. , 1988, Cancer research.

[7]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[8]  M. Flens,et al.  Tissue distribution of the multidrug resistance protein. , 1996, The American journal of pathology.

[9]  S. Bates,et al.  Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate. , 1992, Biochemistry.

[10]  S. Akiyama,et al.  Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cell. , 1989, Biochimica et biophysica acta.

[11]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[12]  S. Akiyama,et al.  Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. , 1989, The Journal of biological chemistry.

[13]  T. Aikou,et al.  Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells. , 1996, Biochemical and biophysical research communications.

[14]  T. Furukawa,et al.  Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues. , 1991, Biochimica et biophysica acta.

[15]  I. Pastan,et al.  Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. , 1986, The Journal of biological chemistry.

[16]  S. Bates,et al.  Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. , 1989, The Journal of biological chemistry.

[17]  M C Willingham,et al.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.